News

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...
Dow Jones Top Company Headlines at 3 PM ET: New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel | Walmart ... New Allegations About Timing of Pfizer Covid Vaccine Passed to ...
Dow Jones Top Company Headlines at 9 PM ET: Meta Is Delaying the Rollout of Its Flagship AI Model | Trump ... The company’s struggle to improve the capabilities of latest AI model mirrors issues at ...
Celcuity Inc. has recently released its 10-Q report, providing a detailed update on its financial status and operational ...
The stock's fall snapped a four-day winning streak.
Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.
Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...
In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other high volume stock. On May 9 ... has provided better performance and protection year-to-date ...
With the stock currently trading at Rs 641.90, Syngene International showcases a moderate uptrend in today's session, amidst ...
We sifted through stock screeners ... stance on Pfizer Inc. (NYSE:PFE) the next day, giving it a buy rating. The analyst said that the company’s fiscal Q1 2025 financial performance reflects ...
On May 21, analyst Geoff Meacham of Citi maintained a Hold rating on Pfizer Inc. (NYSE:PFE), reiterating the price target of ...